https://methylationinhibitor.c....om/index.php/central
A randomized double-blind managed research of ninety (9 women divided in to three equal teams team C (given nebulization of saline 0.9% placebo in four mL), team N (offered nebulization of 20 µ/kg neostigmine and 10 µ/kg atropine diluted in four mL normal saline), and group D (given nebulization of dexmedetomidine 1 µg/kg diluted in four mL normal saline). Nebulization was done twice daily for 3 days, and a Visual Analogue Scale discomfort score (VAS) was recorded for seventy